These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23874525)

  • 121. Pinning down cell signaling, cancer and Alzheimer's disease.
    Lu KP
    Trends Biochem Sci; 2004 Apr; 29(4):200-9. PubMed ID: 15082314
    [TBL] [Abstract][Full Text] [Related]  

  • 122. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
    Ayala G; Wang D; Wulf G; Frolov A; Li R; Sowadski J; Wheeler TM; Lu KP; Bao L
    Cancer Res; 2003 Oct; 63(19):6244-51. PubMed ID: 14559810
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics.
    Lu KP
    Cancer Cell; 2003 Sep; 4(3):175-80. PubMed ID: 14522251
    [No Abstract]   [Full Text] [Related]  

  • 124. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions.
    Galat A
    Curr Top Med Chem; 2003; 3(12):1315-47. PubMed ID: 12871165
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
    Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
    Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.
    Messenger MM; Saulnier RB; Gilchrist AD; Diamond P; Gorbsky GJ; Litchfield DW
    J Biol Chem; 2002 Jun; 277(25):23054-64. PubMed ID: 11940573
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1.
    Pathan N; Aime-Sempe C; Kitada S; Basu A; Haldar S; Reed JC
    Neoplasia; 2001; 3(6):550-9. PubMed ID: 11774038
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
    Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
    Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
    Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
    EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
    Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
    FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
    [TBL] [Abstract][Full Text] [Related]  

  • 131. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.
    Shen M; Stukenberg PT; Kirschner MW; Lu KP
    Genes Dev; 1998 Mar; 12(5):706-20. PubMed ID: 9499405
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.
    Yaffe MB; Schutkowski M; Shen M; Zhou XZ; Stukenberg PT; Rahfeld JU; Xu J; Kuang J; Kirschner MW; Fischer G; Cantley LC; Lu KP
    Science; 1997 Dec; 278(5345):1957-60. PubMed ID: 9395400
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Quantitative synthesis in systematic reviews.
    Lau J; Ioannidis JP; Schmid CH
    Ann Intern Med; 1997 Nov; 127(9):820-6. PubMed ID: 9382404
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Bias in meta-analysis detected by a simple, graphical test.
    Egger M; Davey Smith G; Schneider M; Minder C
    BMJ; 1997 Sep; 315(7109):629-34. PubMed ID: 9310563
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent.
    Ranganathan R; Lu KP; Hunter T; Noel JP
    Cell; 1997 Jun; 89(6):875-86. PubMed ID: 9200606
    [TBL] [Abstract][Full Text] [Related]  

  • 136. A human peptidyl-prolyl isomerase essential for regulation of mitosis.
    Lu KP; Hanes SD; Hunter T
    Nature; 1996 Apr; 380(6574):544-7. PubMed ID: 8606777
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Meta-analysis in clinical trials.
    DerSimonian R; Laird N
    Control Clin Trials; 1986 Sep; 7(3):177-88. PubMed ID: 3802833
    [TBL] [Abstract][Full Text] [Related]  

  • 138. A general parametric approach to the meta-analysis of randomized clinical trials.
    Whitehead A; Whitehead J
    Stat Med; 1991 Nov; 10(11):1665-77. PubMed ID: 1792461
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis.
    Li Q; Dong Z; Lin Y; Jia X; Li Q; Jiang H; Wang L; Gao Y
    PLoS One; 2013; 8(7):e68148. PubMed ID: 23874525
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.